MBNL1 and metastatic malignant neoplasm in the lymph nodes: Additional clinical support showed reduction of MBNL1-AS1 in NSCLC tissue of patients with lymph node metastasis vs. normal adjacent tissue and NSCLC tissue from patients without lymph node metastasis.